An established patient base, transferable insurance contracts, and immediate cash flow make acquisition the dominant path for most optometrists — but de novo isn't off the table if you know what you're signing up for.
For optometrists ready to own their practice, the core decision is straightforward in theory but complex in execution: acquire an existing practice with an active patient panel, insurance contracts, and staff in place, or build a new practice from the ground up. The U.S. optometry market is highly fragmented — tens of thousands of independent practices serve communities nationwide — creating a robust supply of acquisition targets at 3x–5.5x EBITDA. At the same time, de novo practices remain viable in underserved markets or for buyers who want to build their own brand and culture without inheriting someone else's systems. This analysis walks through the financial realities, strategic tradeoffs, and key questions to answer before choosing your path.
Find Optometry Practice Businesses to AcquireAcquiring an established optometry practice gives you immediate access to a patient base of 2,000 or more active patients, working insurance contracts with VSP, EyeMed, and regional payers, a trained staff with existing credentialing, and optical retail revenue from day one. You're paying for proven cash flow — not a projection — and SBA 7(a) financing makes it possible to close with as little as 10–20% equity down.
Optometrists transitioning out of associate employment into first-time ownership, neighboring practice owners seeking geographic expansion, and PE-backed vision care consolidators adding locations in established markets
Starting a de novo optometry practice means selecting your own location, building out the space, purchasing new equipment, credentialing with payers from scratch, and growing a patient base through marketing and community presence. It offers maximum control over brand, culture, and systems design — but demands patience, capital, and a long runway before the practice generates meaningful income.
Optometrists who have identified a genuinely underserved market with limited competition, buyers who cannot find a suitable acquisition target in their target geography, and ODs who have a specific brand or clinical model vision that cannot be retrofitted onto an existing practice
For the vast majority of optometrists and investors entering the market, acquiring an established practice is the superior path. The combination of immediate patient revenue, transferable insurance contracts, SBA-accessible financing, and an active optical dispensary makes acquisition financially and operationally far less risky than de novo. The U.S. optometry market — driven by thousands of retiring ODs aged 55–70 — offers abundant deal flow at reasonable multiples of 3x–5.5x EBITDA. De novo development makes strategic sense only in a small set of circumstances: you've identified a true coverage gap with no competing independent practice, you have 18–36 months of living capital reserves, or you have a highly specific practice model that cannot be adapted from an existing operation. If you can find a practice with 2,000+ active patients, a diversified payer mix, modern equipment, and a motivated seller willing to stay through a 12–24 month transition, buy it.
Is there a qualifying acquisition target — $800K+ in revenue, 2,000+ active patients, 20%+ EBITDA margin — available within your target geography, or is the local market fully consolidated with no realistic deal flow?
Do you have 10–20% equity capital ($80K–$400K) available to fund an SBA acquisition, or are your liquid assets better sized for a de novo startup requiring $300K–$600K in upfront build-out?
Can you negotiate a seller transition agreement of at least 12 months and verify that the existing OD's patient relationships are distributed across the panel rather than concentrated in a small cohort of high-loyalty patients?
Have you independently assessed the condition and replacement cost of all diagnostic equipment — OCT, auto-refractor, slit lamp, digital retinal camera — to confirm no major capital expenditure is hidden in the deal price?
Are you prepared for the operational complexity of the state you're entering, including corporate practice of medicine restrictions, payer credentialing timelines, and whether the existing insurance contracts are assignable to a new owner without re-negotiation?
Browse Optometry Practice Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Most independent optometry practices in the lower middle market sell at 3x–5.5x EBITDA or roughly 0.6x–1.2x annual revenue depending on patient base quality, payer mix, equipment condition, and lease terms. A practice generating $1.5M in revenue with a 25% EBITDA margin would carry an EBITDA of $375K and a likely sale price of $1.1M–$2.1M. Practices with strong optical retail, modern technology, and a documented recall program command the higher end of that range.
Yes. Optometry practice acquisitions are among the most SBA-eligible healthcare transactions. SBA 7(a) loans typically cover 80–90% of the purchase price with a 10-year repayment term on goodwill and up to 25 years on real estate. You'll need to inject 10–20% equity — usually $80K–$400K for a practice in the $800K–$2M revenue range — and the seller often carries a subordinated note of 10–20% to bridge any SBA coverage gap. Working with an SBA lender experienced in healthcare acquisitions is critical, as they understand how to structure the deal around equipment appraisals and lease assignments.
A minimum of 12 months is advisable; 18–24 months is ideal for practices where the seller has strong personal patient relationships. The transition period should be structured as a paid employment or independent contractor agreement with defined clinical hours and a clear patient introduction protocol. Abrupt departures — especially without formal patient communication — are the leading cause of post-acquisition attrition. Buyers should negotiate transition terms before closing and tie a portion of any seller note to retention benchmarks if patient concentration risk is elevated.
Insurance contracts with plans like VSP, EyeMed, Spectera, Medicaid, and commercial payers do not automatically transfer to a new owner in an asset purchase. Each payer has its own credentialing and contract assignment process. Some plans will honor a notice of change of ownership and credential the new OD quickly; others require a full re-application, which can take 60–120 days. During that window, the practice can see patients but may not be able to bill under those plans. Buyers should begin payer notifications immediately at or before close and consult a healthcare attorney familiar with optometry credentialing to minimize billing disruption.
The five most consequential red flags are: (1) declining active patient count over the trailing 24 months without a clear explanation such as associate departure; (2) a payer mix dominated by a single managed vision care plan that could terminate or reprice contracts post-sale; (3) diagnostic equipment that is fully depreciated, unmaintained, or missing core technology like OCT that modern patient expectations require; (4) no associate OD in place, making the entire practice dependent on the selling doctor's personal patient relationships; and (5) commingled personal expenses, undocumented add-backs, or financial statements prepared exclusively by the seller's bookkeeper without CPA review. Any of these warrants either a price reduction or renegotiation of transition terms.
Optometry practice goodwill is typically split between enterprise goodwill — value tied to the practice's systems, brand, location, and patient base that transfers with ownership — and personal goodwill, which is attached to the selling OD's relationships and may not survive the transition. Enterprise goodwill is more valuable to a buyer and generally receives more favorable tax treatment in the allocation. Practices with documented recall systems, associate ODs who see a share of patients, and a strong optical dispensary brand carry higher enterprise goodwill. A qualified healthcare practice broker or CPA experienced in medical practice sales can model this split and ensure the purchase price allocation is defensible to the IRS.
More Optometry Practice Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers